Your browser doesn't support javascript.
loading
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.
Zelniker, Thomas A; Wiviott, Stephen D; Raz, Itamar; Im, KyungAh; Goodrich, Erica L; Furtado, Remo H M; Bonaca, Marc P; Mosenzon, Ofri; Kato, Eri T; Cahn, Avivit; Bhatt, Deepak L; Leiter, Lawrence A; McGuire, Darren K; Wilding, John P H; Sabatine, Marc S.
  • Zelniker TA; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Wiviott SD; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Raz I; The Diabetes Unit, Division of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Israel (I.R., O.M., A.C.).
  • Im K; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Goodrich EL; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Furtado RHM; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Bonaca MP; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Mosenzon O; The Diabetes Unit, Division of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Israel (I.R., O.M., A.C.).
  • Kato ET; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Japan (E.T.K.).
  • Cahn A; The Diabetes Unit, Division of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Israel (I.R., O.M., A.C.).
  • Bhatt DL; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
  • Leiter LA; Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Canada (L.A.L.).
  • McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.).
  • Wilding JPH; Institute of Ageing and Chronic Disease, University of Liverpool, United Kingdom (J.P.H.W.).
  • Sabatine MS; Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (T.A.Z., S.D.W., K.A.I., E.L.G., R.H.M.F., M.P.B., D.L.B., M.S.S.).
Circulation ; 139(17): 2022-2031, 2019 04 23.
Article en En | MEDLINE | ID: mdl-30786725

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Cardiomiopatías Diabéticas / Receptores de Péptidos Similares al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes / Enfermedades Renales Tipo de estudio: Etiology_studies / Prognostic_studies / Systematic_reviews Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Cardiomiopatías Diabéticas / Receptores de Péptidos Similares al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes / Enfermedades Renales Tipo de estudio: Etiology_studies / Prognostic_studies / Systematic_reviews Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article